Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID‐19 in Parkinson’s Disease Patients Living in Lombardy, Italy
Alfonso Fasano, Emanuele Cereda, Michela Barichella, et al.
Movement Disorders (2020) Vol. 35, Iss. 7, pp. 1089-1093
Open Access | Times Cited: 142

Showing 1-25 of 142 citing articles:

Parkinson's disease
Bastiaan R. Bloem, Michael S. Okun, Christine Klein
The Lancet (2021) Vol. 397, Iss. 10291, pp. 2284-2303
Open Access | Times Cited: 2219
Perspective: Vitamin D deficiency and COVID‐19 severity – plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis
Jonathan M. Rhodes, Sreedhar Subramanian, Éamon Laird, et al.
Journal of Internal Medicine (2020) Vol. 289, Iss. 1, pp. 97-115
Open Access | Times Cited: 233
COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside
David Sulzer, Angelo Antonini, Valentina Leta, et al.
npj Parkinson s Disease (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 165
Evidence for possible association of vitamin D status with cytokine storm and unregulated inflammation in COVID-19 patients
Ali Daneshkhah, Vasundhara Agrawal, Adam Eshein, et al.
Aging Clinical and Experimental Research (2020) Vol. 32, Iss. 10, pp. 2141-2158
Open Access | Times Cited: 157
A Basic Review of the Preliminary Evidence That COVID-19 Risk and Severity Is Increased in Vitamin D Deficiency
Linda Benskin
Frontiers in Public Health (2020) Vol. 8
Open Access | Times Cited: 154
COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Barrier Relevance
Aneesha Achar, Chaitali Ghosh
Cells (2020) Vol. 9, Iss. 11, pp. 2360-2360
Open Access | Times Cited: 150
Effects of Vitamin D on COVID-19 Infection and Prognosis: A Systematic Review
Hiwot Yisak, Amien Ewunetei, Belayneh Kefale, et al.
Risk Management and Healthcare Policy (2021) Vol. Volume 14, pp. 31-38
Open Access | Times Cited: 124
Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: A systematic review, meta-analysis and call for action
Lin Liu, Shuyu Ni, Wei Yan, et al.
EClinicalMedicine (2021) Vol. 40, pp. 101111-101111
Open Access | Times Cited: 112
The Impact of the COVID-19 Pandemic on Psychological Distress, Physical Activity, and Symptom Severity in Parkinson’s Disease
Anouk van der Heide, Marjan J. Meinders, Bastiaan R. Bloem, et al.
Journal of Parkinson s Disease (2020) Vol. 10, Iss. 4, pp. 1355-1364
Open Access | Times Cited: 114
Parkinson’s Disease and the COVID-19 Pandemic
Conor Fearon, Alfonso Fasano
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 2, pp. 431-444
Open Access | Times Cited: 84
Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region
Eleonora Del Prete, Alessio Francesconi, Giovanni Palermo, et al.
Journal of Neurology (2020) Vol. 268, Iss. 4, pp. 1179-1187
Open Access | Times Cited: 83
Vitamin D and COVID-19: evidence and recommendations for supplementation
George E. Griffin, Martin Hewison, Julian M. Hopkin, et al.
Royal Society Open Science (2020) Vol. 7, Iss. 12, pp. 201912-201912
Open Access | Times Cited: 79
Neurological Manifestations in COVID-19 Patients: A Meta-Analysis
D. Vitalakumar, Ankita Sharma, Anoop Kumar, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 15, pp. 2776-2797
Closed Access | Times Cited: 76
Predictors of COVID-19 outcome in Parkinson's disease
Alfonso Fasano, Antonio Emanuele Elia, Carlo Dallocchio, et al.
Parkinsonism & Related Disorders (2020) Vol. 78, pp. 134-137
Open Access | Times Cited: 74
The impact of COVID-19 and social distancing on people with Parkinson’s disease: a survey study
Megan Feeney, Yaqian Xu, Matthew Surface, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 74
Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic
Saikat Dewanjee, V. Jayalakshmi, Rajkumar Singh Kalra, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 9, pp. 4694-4715
Open Access | Times Cited: 65
The impact of Parkinson's disease on manifestations and outcomes of Covid‐19 patients: A systematic review and meta‐analysis
Amr Ehab El‐Qushayri, Sherief Ghozy, Abdullah Reda, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Open Access | Times Cited: 62
Alzheimer’s and Parkinson’s Diseases Predict Different COVID-19 Outcomes: A UK Biobank Study
Yizhou Yu, Marco Travaglio, Rebeka Popovic, et al.
Geriatrics (2021) Vol. 6, Iss. 1, pp. 10-10
Open Access | Times Cited: 59
Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms
Pei Huang, Linyuan Zhang, Yuyan Tan, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 31
Vitamin D supplementation and outcomes in coronavirus disease 2019 (COVID-19) patients from the outbreak area of Lombardy, Italy
Emanuele Cereda, Laura Bogliolo, Federica Lobascio, et al.
Nutrition (2020) Vol. 82, pp. 111055-111055
Open Access | Times Cited: 68
Coronavirus Disease 2019 Case Fatality and Parkinson's Disease
Qiang Zhang, Jordan L. Schultz, Georgina M. Aldridge, et al.
Movement Disorders (2020) Vol. 35, Iss. 11, pp. 1914-1915
Open Access | Times Cited: 66
Impact of Coronavirus Disease 2019 Pandemic on Parkinson's Disease: A Cross‐Sectional Survey of 568 Spanish Patients
Diego Santos‐García, M. B. Oreiro, Patricia Pérez, et al.
Movement Disorders (2020) Vol. 35, Iss. 10, pp. 1712-1716
Open Access | Times Cited: 63
The link between vitamin D and COVID‐19: distinguishing facts from fiction
Peter Bergman
Journal of Internal Medicine (2020) Vol. 289, Iss. 1, pp. 131-133
Open Access | Times Cited: 57
Vitamin D and COVID-19: An Overview of Recent Evidence
Drishti P. Ghelani, Simon Alesi, Aya Mousa
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10559-10559
Open Access | Times Cited: 56
Video-Based Analyses of Parkinson’s Disease Severity: A Brief Review
Krista Sibley, Christine Girges, Ehsan Hoque, et al.
Journal of Parkinson s Disease (2021) Vol. 11, Iss. s1, pp. S83-S93
Open Access | Times Cited: 55
Page 1 - Next Page

Scroll to top